Literature DB >> 35034245

Circ-FAT1 Up-Regulates FOSL2 Expression by Sponging miR-619-5p to Facilitate Colorectal Cancer Progression.

Wanli Ma1, Zhong Niu2, Dongfeng Han1, Bingjie Wang1, Xiangsheng Wang1.   

Abstract

Circular RNA FAT atypical cadherin 1 (circ-FAT1) has been reported to play roles in colorectal cancer (CRC) development. Here, the purpose of this study was to investigate the function and mechanism of circ-FAT1 in CRC tumorigenesis and its potential value in the clinic. Levels of genes and proteins were examined by quantitative real-time polymerase chain reaction and Western blot. In vitro assays were conducted using cell counting kit-8 assay, 5-Ethynyl-2'-deoxyuridine assay, flow cytometry, transwell assay, and tube formation assay, respectively. The target relationship between miR-619-5p and circ-FAT1 or FOS-like antigen 2 (FOSL2) was verified by dual-luciferase reporter and RNA immunoprecipitation assays. In vivo assay was performed using a mouse subcutaneous xenograft model. Circ-FAT1 and FOSL2 were highly expressed in CRC tissues and cells. Functionally, knockdown of circ-FAT1 or FOSL2 suppressed CRC cell apoptosis, migration, invasion, and angiogenesis, but induced cell apoptosis in vitro. Mechanistically, circ-FAT1 acted as a sponge for miR-619-5p to up-regulate the expression of FOSL2, which was confirmed to be a target of miR-619-5p. A series of rescue experiments demonstrated that miR-619-5p inhibition or FOSL2 overexpression reversed the inhibitory action of circ-FAT1 silencing on CRC cell malignant phenotypes mentioned above. Pre-clinically, lentivirus-mediated circ-FAT1 knockdown inhibited the tumorigenesis of CRC xenografts in nude mice via regulating miR-619-5p and FOSL2. Circ-FAT1 knockdown repressed FOSL2 expression by sponging miR-619-5p to suppress CRC tumorigenesis, providing a potential approach for CRC therapeutics.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Apoptosis; Circ-FAT1; Colorectal cancer; FOSL2; miR-619-5p

Mesh:

Substances:

Year:  2022        PMID: 35034245     DOI: 10.1007/s10528-021-10148-6

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   2.220


  5 in total

1.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

2.  Circular RNA circRNA_0000285 promotes cervical cancer development by regulating FUS.

Authors:  R-X Chen; H-L Liu; L-L Yang; F-H Kang; L-P Xin; L-R Huang; Q-F Guo; Y-L Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-10       Impact factor: 3.507

3.  Osteoblast-specific expression of Fra-2/AP-1 controls adiponectin and osteocalcin expression and affects metabolism.

Authors:  Aline Bozec; Latifa Bakiri; Maria Jimenez; Evan D Rosen; Philip Catalá-Lehnen; Thorsten Schinke; Georg Schett; Michael Amling; Erwin F Wagner
Journal:  J Cell Sci       Date:  2013-09-17       Impact factor: 5.285

Review 4.  Biomarkers in Colorectal Cancer.

Authors:  Andrew J Yiu; Chu Y Yiu
Journal:  Anticancer Res       Date:  2016-03       Impact factor: 2.480

Review 5.  Worldwide variations in colorectal cancer.

Authors:  Melissa M Center; Ahmedin Jemal; Robert A Smith; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2009 Nov-Dec       Impact factor: 508.702

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.